PSA Levels No Different With Exposure to Antidiabetes Meds
Regardless of PSA levels triggering biopsy, no difference in prostate cancer detection at biopsy.
Prostate Cancer
Pathogenic, Likely Pathogenic Variants Common in Prostate Cancer
Variety of ethnicities need to be included in studies of germline testing to better understand variants.
Prostate Cancer Active Surveillance Appropriate for Blacks
Active surveillance (AS) is an appropriate management strategy for black men with favorable-risk prostate cancer (PCa) who adhere to a standardized protocol of regular PSA tests and biopsies, investigators reported. The prospective, multi-institutional cohort Canary Prostate Cancer Active Surveillance Study (PASS), which included 1315 men on AS, found that black men were at no higher…
Investigating the Role of Salvage Lymph Node Dissection in Nonmetastatic CRPC
Traditionally, approaches to the management of patients with nonmetastatic CRPC following radical prostatectomy have been limited.
Transperineal Prostate Biopsy May Be a Safer Alternative
Transrectal and transperineal prostate biopsies offer similar prostate cancer detection rates, but the transperineal approach is associated with a lower risk of infectious-related complications, a study found.
Early ADT for Recurrent Prostate Cancer Challenged
Men with biochemically recurrent nonmetastatic prostate cancer following radical prostatectomy have long survival times from the time of surgery without hormonal treatment, a study found.
Prostate Cancer Risk Higher Among Men With IBD
Men with ulcerative colitis may be particularly at risk for prostate cancer, according to researchers.
Prostate Cancer Salvage Combo Benefits Confirmed
A post-hoc analysis of a phase 3 trial demonstrated that adding 6 months of androgen deprivation therapy to salvage radiotherapy for recurrent prostate cancer following radical prostatectomy improves progression-free survival at 120 months.
ASCO Releases Guideline on Addressing Osteoporosis Risk With Nonmetastatic Cancer
The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures.
Whole Pelvis Radiotherapy for High-Risk Prostate Cancer May Improve Outcomes
Whole pelvis radiotherapy (WPRT) may improve treatment outcomes among patients with intermediate- or high-risk prostate cancer compared with prostate-only radiotherapy (PORT), a new study suggests. A team led by Peter J. Hoskin, MD, PhD, of Southampton General Hospital in Southampton, UK, compared the approaches in a prospective cohort study that included 812 men with intermediate-…
Next post in Prostate Cancer
